Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
107,809,066
-
Total 13F shares
-
61,777,039
-
Share change
-
+410,878
-
Total reported value
-
$8,288,248,318
-
Put/Call ratio
-
108%
-
Price per share
-
$134.15
-
Number of holders
-
355
-
Value change
-
+$33,759,132
-
Number of buys
-
193
-
Number of sells
-
151
Institutional Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q3 2021
As of 30 Sep 2021 Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) had 355 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,777,039 shares of stock of the company.
Largest 10 holders included ARK Investment Management LLC, VANGUARD GROUP INC, BlackRock Inc., FMR LLC, Nikko Asset Management Americas, Inc., Sumitomo Mitsui Trust Holdings, Inc., PRICE T ROWE ASSOCIATES INC /MD/, STATE STREET CORP, VIKING GLOBAL INVESTORS LP, and ALLIANCEBERNSTEIN L.P..
This table shows 358 institutional shareholders of the security as of 30 Sep 2021.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.